Background: Natriuretic peptides are useful markers for risk stratification of patients with heart disease. However, conflicting results have been reported about circulating atrial natriuretic peptide (ANP) concentration in heart transplant recipients.

Methods: To ascertain the effects of diabetes and acute insulin administration on plasma ANP concentrations in a model of heart denervation, we studied 12 diabetic (D-OHT) and 6 nondiabetic heart-transplanted (OHT) patients using the euglycemic-hyperinsulinemic clamp and oral glucose tolerance tests. Five patients with type 2 diabetes without heart transplantation (D) and 9 healthy subjects (NOR) matched for anthropometric features served as the controls.

Results: Means baseline plasma ANP concentration was higher in D-OHT (82 +/- 15 pg/mL) than in OHT or NOR (27 +/- 4 or 30 +/- 5; P < .01), but was not different than D (69 +/- 12; P = .82). During the clamp plasma ANP showed similar increases in all groups (49 +/- 4, 39 +/- 3, 59 +/- 4, and 49 +/- 3% in D-OHT, OHT, D, and NOR; P < .02 vs basal, P = NS among groups). Plasma osmolarity and catecholamines were also not different among groups and did not increase during the clamp. Fasting plasma ANP concentrations correlated with plasma glucose concentrations measured 120 minutes after oral glucose tolerance testing.

Conclusions: Among heart transplantation recipients fasting plasma ANP concentrations were not different at 5 to 6 years after the surgical procedure than in nondiabetic controls. Increased ANP concentrations were observed among recipients with diabetes and among nontransplanted diabetic patients. Although the insulin-induced increment in ANP concentrations was not different among groups, circulating ANP was strongly associated with glucose tolerance status.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2007.04.020DOI Listing

Publication Analysis

Top Keywords

plasma anp
20
anp concentrations
20
+/- +/-
20
heart transplantation
12
glucose tolerance
12
anp
9
atrial natriuretic
8
natriuretic peptide
8
patients heart
8
anp concentration
8

Similar Publications

Chronic pressure overload induces adverse cardiac remodelling characterised by left ventricular (LV) hypertrophy and fibrosis, leading to heart failure (HF). Identification of new biomarkers for adverse cardiac remodelling enables us to better understand this process and, consequently, to prevent HF. We recently identified clusterin (CLU) as a biomarker of cardiac remodelling and HF after myocardial infarction.

View Article and Find Full Text PDF
Article Synopsis
  • Malondialdehyde (MDA) is identified as a potential predictor of inhospital mortality in patients with acute coronary syndrome (ACS), a condition with limited research on this marker compared to stable angina pectoris.
  • The study involved 556 ACS patients, using leftover plasma samples to analyze various blood markers, including MDA, troponin, and others, in relation to inhospital mortality.
  • Results showed that MDA levels, along with age and creatine, were independent predictors of inhospital mortality, with an optimal MDA cutoff value of >33.1 providing high sensitivity (85%) and specificity (88.17%) for predicting outcomes.
View Article and Find Full Text PDF

Protective Role of (-)-Epicatechin on Trimethylamine-N-Oxide (TMAO)-Induced Cardiac Hypertrophy via SP1/SIRT1/SUMO1 Signaling Pathway.

Cardiovasc Toxicol

December 2024

Department of Cardiology, First Affiliated Hospital, Harbin Medical University, No. 23 YouZheng Street, NanGang District, Harbin, 150001, Heilongjiang, China.

Article Synopsis
  • (-)-Epicatechin (EPI) shows potential benefits for heart health by inhibiting TMAO-induced cardiac hypertrophy, which is linked to cardiovascular diseases.
  • The study involved both mouse models and heart cells to evaluate the effects of EPI on TMAO-induced cardiac issues, measuring outcomes through plasma TMAO levels and histological heart analyses.
  • Results indicated that EPI not only improved cardiac function but also countered the harmful effects of TMAO, including the regulation of various cardiac hypertrophy markers.
View Article and Find Full Text PDF
Article Synopsis
  • Type 2 diabetes (T2D) and obesity are linked to low levels of natriuretic peptide (NP) and reduced NP guanylyl cyclase receptor-A (GCA) in muscles and fat tissue.
  • Research in mice shows that lack of ANP/GCA leads to metabolic issues and prediabetes, causing insulin resistance and poor endurance.
  • ANP/GCA is crucial for maintaining mitochondrial function and oxidative capacity in skeletal muscle, suggesting it plays a key role in the development of prediabetes.
View Article and Find Full Text PDF

In the proximal tubules of the kidney, angiotensin II (ANG II) binds and activates ANG II type 1 (AT) receptors to stimulate proximal tubule Na reabsorption, whereas atrial natriuretic peptide (ANP) binds and activates natriuretic peptide receptors (NPR) to inhibit ANG II-induced proximal tubule Na reabsorption. These two vasoactive systems play important counteracting roles to control Na reabsorption in the proximal tubules and help maintain blood pressure homeostasis. However, how AT and NPR receptors interact in the proximal tubules and whether natriuretic effects of NPR receptor activation by ANP may be potentiated by deletion of AT (AT) receptors selectively in the proximal tubules have not been studied previously.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!